Loading…
Longitudinal comparisons of a whole‐mouth taste test to clinician‐rated and patient‐reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake
Background After head and neck cancer (HNC) treatment, dysgeusia may be a barrier to oral intake. In this exploratory study, we prospectively examined taste perception, clinician‐rated (CRO) and patient‐reported (PRO) taste changes and their effect on oral intake postradiotherapy. Methods Twenty‐eig...
Saved in:
Published in: | Head & neck 2021-07, Vol.43 (7), p.2159-2177 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
After head and neck cancer (HNC) treatment, dysgeusia may be a barrier to oral intake. In this exploratory study, we prospectively examined taste perception, clinician‐rated (CRO) and patient‐reported (PRO) taste changes and their effect on oral intake postradiotherapy.
Methods
Twenty‐eight patients were assessed at baseline, treatment weeks 2 and 4, and 1, 3, and 6 months post‐treatment using a whole‐mouth taste test and associated CRO and subjective PRO measures.
Results
Greater taste impairment was reflected by subjective than by a whole‐mouth taste test. The most significant and consistent decline occurred mid‐treatment. The Chemotherapy‐Induced Taste Alteration Scale (PRO) discomfort subscale correlated significantly with maintaining an oral diet, percent of oral intake, and appetite level from mid‐treatment to 6 months post‐treatment.
Conclusions
PRO results indicated ongoing oral intake issues. Whole‐mouth taste tests may fail to fully reflect functional taste‐loss. Dysgeusia prevention and treatment methods are needed to improve patient outcomes. |
---|---|
ISSN: | 1043-3074 1097-0347 |
DOI: | 10.1002/hed.26690 |